Recent Articles from Business Wire

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to accelerate the next generation of oncology breakthroughs leveraging its foundational model. The PRECISION Challenge aims to unlock breakthroughs in oncology at scale by providing access to data, funding, and expertise to multidisciplinary teams around the world who seek to make bold advances in cancer treatment and improve patient outcomes.

Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer (mCRC) co-sponsored by Summit and Akeso, featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab. The data were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Prostate test identifies which men with metastatic prostate cancer benefit from adding the chemotherapy docetaxel to standard hormonal therapy (ADT plus enzalutamide), known as triplet therapy, and who can safely avoid it, providing the first Level 1B 1 evidence for a genomic test guiding this decision. Complementary data presented at the meeting also reinforce Decipher Prostate's clinical utility in high-risk localized disease.

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the introduction of Tempus Preview, an application providing rapid, clinically significant insights that close the gap between the time of order and delivery of insights. Representing a significant paradigm shift in precision oncology workflows, Tempus Preview offers preliminary results in the critical window between when a diagnostic test is ordered and when final sequencing results are delivered by surfacing key mutation predictions within approximately 24 hours of tissue receipt.

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the global, randomized, double-blind, placebo-controlled Phase 3 trial of varegacestat in patients with progressing desmoid tumors. The data are being presented today in an oral abstract session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Immunome submitted an NDA for varegacestat to the FDA in April 2026.

Pfizer Inc. (NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in men with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC). These results will be presented today in a late-breaking oral presentation (Abstract LBA5007) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The New England Journal of Medicine.

Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of Liver (EASL) Congress in Barcelona, Spain, demonstrating the first clinical evidence of epigenetic silencing in hepatitis B virus (HBV).

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the signing of a definitive agreement to acquire up to 102 Mission Pet Health (“MPH”) veterinary properties for a purchase price of up to $268.0 million from Shore Capital Real Estate Partners Fund I.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AeroVironment, Inc. (NASDAQ: AVAV) securities between June 25, 2025 and March 10, 2026, both dates inclusive (the “Class Period”), have until July 27, 2026 to seek appointment as lead plaintiff of the AeroVironment class action lawsuit. Captioned Norrell v. AeroVironment, Inc., No. 26-cv-01429 (E.D. Va.), the AeroVironment class action lawsuit charges AeroVironment and certain of AeroVironment’s top current and former executive officers with violations of the Securities Exchange Act of 1934.

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Lucid Group, Inc. (NASDAQ: LCID) securities between February 25, 2026 and April 13, 2026. Lucid is a technology company that designs, develops, manufactures, and sells electric vehicles (“EVs”), EV powertrains, and battery systems.

Ferrari Films founder, attorney, and producer Stacy Kemp Ferrari today issued a point-by-point rebuttal to a Forbes article asserting that Section 168(k) of the Internal Revenue Code is "worthless as a tax shelter to raise financing for films." Ferrari contends the article contains critical legal oversights that, if left unchallenged, could mislead investors and producers who may have entirely lawful and well-structured grounds to benefit from the statute.

The law firm of Kirby McInerney LLP continues its investigation on behalf of York Space Systems Inc. (“York Space Systems” or the “Company”) (NYSE:YSS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

Tanner Health, a leading nonprofit healthcare system serving west Georgia and east Alabama, today announced its go-live with Hyro, the leading Responsible AI Assistant Platform for health care, to streamline patient access and improve call center efficiency.

KBRA assigns a long-term rating of AA+ with a Stable Outlook to the State of Illinois (the "State"), Build Illinois Bonds (Sales Tax Revenue Bonds), Junior Obligation Series A and B of June 2026 (the "Junior Bonds"). KBRA additionally affirms the long-term rating of AA+ with a Stable Outlook for the State's outstanding parity Junior Obligation Build Illinois Bonds.

Syncora Guarantee Inc. (“Syncora Guarantee”) today announced that certain financial information of Syncora Guarantee has been made available on Syncora Guarantee's website (www.syncoraguarantee.com). The information posted is Syncora Guarantee’s Statutory Basis Financial Statements Years Ended December 31, 2025 and 2024 With Report of Independent Auditors.

Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE:MMI) dedicated to serving the company’s institutional clients, announced today that Peter Katz, IPA executive managing director investments, advised Harrison Street Asset Management (HSAM) in HSAM’s sale of a 12-property, 7,578-bed student housing portfolio to a joint venture between Scion Group (Scion) and an Ares Real Estate fund (Ares) for approximately $910 million. Katz was engaged to consult on portfolio strategy and asset composition.

Sable Offshore Corp. (“Sable”)(NYSE: SOC) plans to post a new investor presentation to its corporate website before market open on Monday, June 1, 2026 and plans to host a conference call to discuss the new investor presentation on Monday June 1, 2026 at 10:00am CDT / 11:00am EDT.

Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

Kraken, one of the world’s longest-standing, most liquid and secure cryptocurrency platforms, has set out plans to launch the first CFTC-regulated perpetual futures in the US in the next 30 days.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented new overall survival data from its pivotal Phase 3 ROSELLA trial of Lifyorli™ (relacorilant) plus nab-paclitaxel (a taxane chemotherapy) in an oral presentation at the ASCO 2026 (American Society of Clinical Oncology) Annual Meeting.

Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share:

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals.

The Principal Real Estate Income Fund (NYSE:PGZ) announces the sources of a distribution paid on May 29, 2026 of $0.1050 per share to shareholders of record at the close of business on May 14, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission and includes the notice below sent to shareholders regarding the source of the distribution.

State Street Corporation (NYSE: STT) announced today that its Chief Financial Officer, John Woods, will present at the Morgan Stanley U.S. Financials Conference in New York, NY on Wednesday, June 10, 2026 at approximately 1:45 pm ET.

QXO, Inc. (“QXO”) (NYSE: QXO) today announced that, in connection with its pending acquisition of TopBuild Corp. (“TopBuild”), it has commenced, through its wholly-owned subsidiary Titanium MergerCo, Inc., a Delaware corporation (the “Company”), tender offers (collectively, the “Tender Offers”) to purchase for cash any and all of the outstanding (i) 4.125% Senior Notes due 2032 (the “2032 Notes”) and (ii) 5.625% Senior Notes due 2034 (the “2034 Notes” and, together with the 2032 Notes, the “Notes”) of TopBuild.

PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY) and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) declared today monthly distributions for June, July and August 2026. The distribution amounts and schedule for each fund appears below:

MFS Investment Management® (MFS®) announced today monthly distributions of the following closed-end funds, all with declaration dates of May 29, 2026, ex-dividend dates of June 8, 2026, record dates of June 8, 2026, and payable dates of June 15, 2026:

PACIFIC COAST OIL TRUST (OTC–ROYTL) (the “Trust”), a royalty trust formed by Pacific Coast Energy Company LP (“PCEC”), announced today that there will be no cash distribution to the holders of its units of beneficial interest of record on May 27, 2026 based on the Trust’s calculation of net profits generated during March 2026 (the “Current Month”) as provided in the conveyance of net profits interests and overriding royalty interest (the “Conveyance”). As further described below under “Update on Estimated Asset Retirement Obligations,” based on information from PCEC, any monthly payments that PCEC may make to the Trust may not be sufficient to cover the Trust’s administrative expenses and outstanding debt to PCEC, and therefore the likelihood of distributions to the unitholders in the foreseeable future is extremely remote. As further described below under “Status of the Dissolution of the Trust”, because the annual cash proceeds received by the Trust from its net profits interests (the “Net Profits Interests”) and 7.5% overriding royalty interest (the “Royalty Interest”) totaled less than $2.0 million for each of 2020 and 2021, the amended and restated trust agreement governing the Trust (the “Trust Agreement”) provides that the Trust is to be dissolved and wound-up. All financial and operational information in this press release has been provided to the Trustee by PCEC.

Essex Property Trust, Inc. (NYSE:ESS) announced today that Angela L. Kleiman, President and CEO, will be participating in a roundtable presentation at the 2026 Nareit REITweek Conference on Wednesday, June 3, 2026 at 2:00 p.m. Eastern Time.

indie Semiconductor (Nasdaq: INDI), an automotive solutions innovator, today announced that it has granted equity awards (the “Inducement Grants”) under its 2023 Inducement Incentive Plan to new employees who joined indie. The grants were previously approved by the Compensation Committee of the Board of Directors of indie Semiconductor. Information regarding the equity awards can be found on the company's investor relations website at: https://investors.indie.inc/news/default.aspx

KKR & Co. Inc. (NYSE: KKR) announced today that Raj Agrawal, Partner and Global Head of Real Assets, will present at the Morgan Stanley US Financials Conference on Wednesday, June 10, 2026 at 8:15 AM ET.

Blackstone Senior Floating Rate 2027 Term Fund (NYSE: BSL, the “Fund”) announced that the Fund’s Board of Trustees (the “Board”) approved an extension of the Fund’s reinvestment period (the “Extension”). The Fund continues to have a limited term and is scheduled to dissolve on or about May 31, 2027 (the “Dissolution Date”). The Extension will permit the Fund to continue to reinvest proceeds generated by maturities, prepayments and sales of investments until the effective date of any plan of liquidation the Board adopts. Previously, the Fund’s reinvestment period was scheduled to end one year prior to the Dissolution Date (i.e., May 31, 2026).

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

Triumph (the “Company”) (NYSE: TFIN) today announced that the Company’s Board of Directors declared a quarterly cash dividend of $17.81 per share on its 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock, represented by depositary shares (NYSE: TFIN-PR), each representing a 1/40th interest in a share of preferred stock. Holders of depositary shares will receive $0.44525 per depositary share. The dividend is payable on June 30, 2026, to holders of record at the close of business on June 15, 2026.

Empire State Realty Trust, Inc. (NYSE: ESRT) (the “Company”), today announced that Christina Chiu, President, Steve Horn, EVP, Chief Financial Officer, and Ryan Kass, EVP, Co-head and Chief Revenue Officer of Real Estate, will participate in a moderated Company presentation at the Nareit REITweek 2026 investor conference on Tuesday, June 2, 2026, from 1:45 p.m. to 2:15 p.m. Eastern Time. The Company presentation will be available via webcast. The live audio-webcast can be accessed in listen-only mode on the “Investors” section of the Company’s website (www.esrtreit.com) under “Presentations”. A replay of the audio-webcast will be available through August 1st, 2026, via the same link.

Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), the operating system for human-agent teams, today announced that Asana’s executives will present at the following investor events:

Tiptree Inc. (NASDAQ: TIPT) (the “Company” or “Tiptree”) and Warburg Pincus LLC (“Warburg Pincus”) today announced the successful closing of the previously disclosed sale of The Fortegra Group, Inc. (“Fortegra”), a leading specialty insurer, to DB Insurance Co., Ltd., Korea’s leading property and casualty insurer.

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Republic Insurance Company (Cayman) Limited (Republic Insurance) (Cayman Islands). The outlook of these Credit Ratings (ratings) is stable.

Moody and mysterious, sexy yet sophisticated, Gigolo is the latest cocktail destination imagined by Lisa Vanderpump, now open at The Vanderpump Hotel.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today results from the independent OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis) trial, led by University College London (UCL). The results, which will be presented at the ASCO Annual Meeting, conclude that the Prosigna® Breast Risk of Recurrence (ROR) test safely guides adjuvant chemotherapy decisions in patients with early-stage, ER-positive HER2-negative breast cancer.

For the release dated May 28, 2026, third paragraph, the date at the end of first sentence should read March 31, 2025 (instead of March 31, 2026).

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Angi Inc. (“Angi” or “the Company”) (NASDAQ: ANGI) for violations of the securities laws.

Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight.

CBL Properties (NYSE: CBL) announced today that it closed a $71.9 million non‑recourse loan secured by Hamilton Place in Chattanooga, Tennessee. The five‑year loan bears a fixed interest rate of 6.8% and replaces the property’s existing $85.5 million loan, which was scheduled to mature in June.

The Eaton Vance closed-end funds listed below released today the estimated sources of their May distributions (each a “Fund”). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the May distribution. It is not determinative of the tax character of a Fund’s distributions for the 2026 calendar year. Shareholders should note that each Fund’s total regular distribution amount is subject to change as a result of market conditions or other factors.

GID, a vertically-integrated real estate owner, operator, developer and investor with $32.8 billion in assets under management, today announced the continued expansion of GID Residential Partners, its national development platform, with a strategic entry into the Boston market. The initiative will be led by industry veteran Chris Spendley, who joins the firm as Managing Director.

Dallas Fire-Rescue crews are investigating and searching debris in the wake of the May 28th natural gas explosion at a residential apartment building in Oak Cliff near Dallas' Bishop Arts District, and the experienced trial attorneys of respected Texas-based personal injury law firm Zehl & Associates are monitoring the situation closely.

Donaldson Company, Inc. (NYSE: DCI) today announced that its Board of Directors declared a regular cash dividend of 32.0 cents per share, an increase of 6.7% from the prior quarterly dividend of 30.0 cents per share. The dividend is payable June 30, 2026, to shareholders of record on June 15, 2026. Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index and calendar year 2025 marked the 30th consecutive year of annual dividend increases. The Company has paid a cash dividend every quarter for 70 years.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Upwork Inc. (“Upwork” or “the Company”) (NASDAQ: UPWK) for violations of the securities laws.

BIMIZCI Fund LLC, Warnke Investments LLC, ZimCal Asset Management, LLC and Stephen Hodges (collectively, "BIMIZCI" or "we"), long-standing holders of Medallion Financial Corp. (NASDAQ: MFIN) ("Medallion" or the "Company") trust preferred securities and currently the 4th largest institutional stockholder with 500,250 shares, announced today that both leading independent proxy advisory firms, Institutional Shareholder Services ("ISS") and Glass, Lewis & Co. ("Glass Lewis"), have recommended that Medallion stockholders vote on the BLUE proxy card FOR the election of BIMIZCI nominees Eric Kelly and John Kiernan to the Company's Board of Directors (the "Board") at the upcoming 2026 Annual Meeting of Stockholders to be held on June 9, 2026. Both ISS and Glass Lewis further recommended that stockholders WITHHOLD support from incumbent Executive Chair Alvin Murstein and Nominating & Governance Committee Chair Cynthia Hallenbeck.

Sallie Mae® (Nasdaq: SLM), formally SLM Corporation, today announced Co-President and Chief Financial Officer Pete Graham will speak at the 2026 Morgan Stanley US Financials Conference on Wednesday, June 10, at 7:30 a.m. ET.

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the launch of FoundationOne®MRD, a molecular residual disease (MRD) test.1 This launch follows the completion of Roche’s acquisition of SAGA Diagnostics. FoundationOne MRD is the first-of-its-kind MRD test to combine structural variants and digital PCR, enabling ultra-sensitive MRD detection, with high specificity.2

Quantum timing is no longer a lab curiosity. Over the past year, Xairos stepped into the spotlight at nine conferences across timing, navigation, and deep tech — and the conversations that followed made it clear: the world is ready for what Xairos is building.

On May 13, 2026, Pagaya Technologies Ltd. (“Pagaya”), together with certain affiliates, filed a lawsuit against Klarna, Inc. (“Klarna”) and Klarna Group plc in the U.S. District Court for the District of Delaware. The lawsuit relates to alleged misappropriation of intellectual property and trade secrets under the Defend Trade Secrets Act of 2016. KBRA maintains ratings on two revolving ABS transactions backed by “buy now, pay later”, point-of-sale consumer loans that were originated or will be originated using Pagaya’s proprietary credit decisioning model through the Klarna platform.

EDF power solutions North America today announced the execution of a 30-year Power Purchase Agreement (PPA) with Southern California Public Power Authority (SCPPA). The PPA covers the output from a 400-megawatt (MW)dc/300 MWac solar project known as the Utah Solar 1 Energy project for participating member Los Angeles Department of Water and Power (LADWP).

Residents of Delaware County will soon have a new option for around-the-clock emergency and inpatient care closer to home. In early June, ChristianaCare will open ChristianaCare Hospital, Aston, a neighborhood hospital designed to expand access to care in a growing region with increasing health care needs.

KBRA assigns ratings of BBB to TPG Twin Brook Capital Income Fund's ("TCAP" or "the company") $50 million, 6.67% senior unsecured notes due June 2029 and its $175 million, 7.03% senior unsecured notes due June 2031. The rating Outlook is Stable. Proceeds will be used for the repayment of secured debt.

Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home-Basing campuses for business aircraft, today announced that it will present and hold investor 1x1 meetings at the 2026 RBC Capital Markets Global Energy, Power & Infrastructure Conference (EPIC), on June 2–3, 2026 at the Westin Grand Central Hotel in New York, NY and the East Coast IDEAS Investor Conference on June 10–11, 2026 at the Westin Times Square Hotel in New York, NY.

The 19(a) monthly distribution notices for Franklin Limited Duration Income Trust (NYSE: FTF) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund’s current distribution and its cumulative distributions paid this fiscal year-to-date. Amounts are expressed on a per share of common stock basis, and as a percentage of the distribution amount.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Photronics, Inc. (“Photronics” or the “Company”) (NASDAQ: PLAB) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”).

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) securities between June 25, 2025 and March 10, 2026, inclusive (the “Class Period”). AeroVironment investors have until July 27, 2026 to file a lead plaintiff motion.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”). Zoetis investors have until July 27, 2026 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz reminds investors of the upcoming June 1, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026, inclusive (the “Class Period”).

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Calix, Inc. (“Calix” or the “Company”) (NYSE: CALX) securities between January 28, 2026 and April 21, 2026, inclusive (the “Class Period”).

TabaPay, the leading money movement platform for innovators, and Evolve Bank & Trust, a leading open banking provider, have expanded a partnership with Coinstar to enhance its Transfer to Account service. Consumers using participating U.S. Coinstar® kiosks can now insert cash or coins and transfer funds directly to the account associated with any eligible debit card. This partnership aims to expand Transfer to Account functionality across more than 10,000 Coinstar kiosks in the United States.

SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)

The full-service transactional and litigation firm Shackelford, McKinley & Norton has bolstered its corporate law expertise with the addition of partners in Dallas and Houston.

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock on the New York Stock Exchange (“NYSE”) of Stellantis N.V. (NYSE: STLA) between February 26, 2025 and February 5, 2026. Stellantis describes itself as a “a global automobile designer, engineer, manufacturer, and distributor.”

Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the EASL Congress 2026 (The European Association for the Study of the Liver) in Barcelona, Spain, that a single intramuscular dose of VRON-0200, its novel, first-in-class, immunotherapy for HBV Functional Cure, induced HBV-specific immune activation, restoration, and continued HBsAg declines, without rebound, up to 2+ years post dosing, in the majority of chronically HBV-infected treated patients with long term follow up. These data, presented as an oral presentation by Professor Edward Gane, M.D., from the University of Auckland, also highlighted VRON-0200’s ongoing favorable safety and tolerability profile, and sustained HBsAg declines, up to 3 months post the last dose of investigational antivirals, when given in combination with a single VRON-0200 prime dose.

The National Association for Veterans Rights (NAVR) today responded to the recent district court ruling in Ford v. Veterans Guardian, warning that the decision could significantly disrupt access to lawful assistance for Veterans navigating the VA disability claims process.

CrowdStrike (NASDAQ: CRWD) today announced it has been named a Leader in the 2026 Gartner® Magic Quadrant™ for Endpoint Protection1 for the seventh consecutive time. CrowdStrike was also positioned furthest right for Completeness of Vision and highest for Ability to Execute among all vendors evaluated for the fourth time in a row.